Connect Biopharma Limite... (CNTB)
NASDAQ: CNTB
· Real-Time Price · USD
1.67
-0.14 (-7.73%)
At close: Aug 20, 2025, 3:58 PM
1.70
1.68%
After-hours: Aug 20, 2025, 07:26 PM EDT
Connect Biopharma Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Jun 30, 2025 | Dec 31, 2024 | Jun 30, 2024 | Dec 31, 2023 | Jun 30, 2023 | Dec 31, 2022 | Jun 30, 2022 | Dec 31, 2021 | Jun 30, 2021 |
Cash & Equivalents | 40.63M | 78.23M | 110.17M | 106.01M | 81.39M | 80.37M | 141.56M | 268.02M | 313.13M |
Short-Term Investments | 31.14M | 15.48M | 67K | 12.65M | 49.82M | 74.67M | 49.34M | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | 9.6M | 22.33M | n/a | n/a |
Other Long-Term Assets | 45K | 33K | 96K | 132K | 735.53K | 34.62K | 72.36K | 2.9M | 2.06M |
Receivables | 193K | 1.05M | 3.85M | n/a | 50.25K | n/a | 433.46K | n/a | 408.04K |
Inventory | n/a | n/a | n/a | -13.95M | 3.48M | 3.18M | 6.7M | n/a | n/a |
Other Current Assets | 228K | 53K | n/a | n/a | 3.05M | n/a | 678.97K | n/a | 722.67K |
Total Current Assets | 77.76M | 96.96M | 115.9M | 120.97M | 137.81M | 158.46M | 198.04M | 275.44M | 324.4M |
Property-Plant & Equipment | 4.88M | 4.24M | 4.52M | 4.73M | 5.09M | 5.47M | 10.76M | 9.5M | 6.18M |
Goodwill & Intangibles | 48K | 53K | 57K | 62K | 64.59K | 3.22M | 3.33M | 3.54M | 3.48M |
Total Long-Term Assets | 4.97M | 4.32M | 4.67M | 4.92M | 5.89M | 18.55M | 36.98M | 15.94M | 11.72M |
Total Assets | 82.72M | 101.28M | 120.57M | 125.89M | 143.7M | 177.01M | 235.02M | 291.39M | 336.12M |
Account Payables | 2.29M | 342K | 5.7M | 7.66M | 11.46M | 11.94M | 15.18M | 12.73M | 10.16M |
Deferred Revenue | 164K | 164K | n/a | 13.32M | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 350K | 154K | n/a | n/a | n/a | n/a | n/a | n/a | 95.1K |
Other Current Liabilities | 1.31M | 95K | 1.71M | 13.76M | 2.46M | 2.69M | 3.76M | 5.15M | 3.39M |
Total Current Liabilities | 10.74M | 8.46M | 9.62M | 24.26M | 14.89M | 15.89M | 20.68M | 18.01M | 14.01M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 74.53K |
Other Long-Term Liabilities | 122K | 632K | n/a | n/a | 161.64K | n/a | 286.00 | 784K | -74.53K |
Total Long-Term Liabilities | 642K | 656K | 467K | 585K | 483.64K | 911.83K | 1.05M | 810.73K | 74.53K |
Total Liabilities | 11.38M | 9.12M | 10.09M | 24.85M | 15.37M | 16.81M | 21.73M | 18.82M | 14.09M |
Total Debt | 870K | 178K | 325K | 465K | 592.68K | 437.88K | 561.91K | 124.52K | 169.63K |
Common Stock | 10K | 10K | 10K | 10K | 9.11K | 9.64K | 9.85K | 10.36K | 10.21K |
Retained Earnings | -368.53M | -345.36M | -531.7M | -539.35M | -467.52M | -463.76M | -414.71M | -373.43M | -311.39M |
Comprehensive Income | -1.38M | -1.67M | 13.48M | -7.88M | 13.76M | 10.39M | 3.85M | -6.48M | -3.17M |
Shareholders Equity | 71.34M | 92.17M | 110.48M | 101.04M | 128.32M | 160.21M | 213.29M | 272.57M | 322.03M |
Total Investments | 31.14M | 15.48M | 67K | 12.65M | 49.82M | 84.27M | 71.67M | n/a | n/a |